Michael Fähling Selected Research

Michael Fähling Research Topics

Disease

11	Hypoxia (Hypoxemia) 10/2022 - 10/2004
7	Neoplasms (Cancer) 06/2022 - 10/2005
3	Neuroblastoma 01/2016 - 01/2011
3	Fibrosarcoma 04/2006 - 10/2004
2	Hypertension (High Blood Pressure) 01/2019 - 08/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2011 - 02/2009
2	Fibrosis (Cirrhosis) 10/2005 - 10/2004
1	Anemia 10/2022
1	Microvascular Rarefaction 10/2022
1	Liver Neoplasms (Liver Cancer) 06/2022
1	Hepatoblastoma 06/2022
1	COVID-19 10/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Atherosclerosis 02/2014
1	Brain Neoplasms (Brain Tumor) 01/2014
1	Glioma (Gliomas) 01/2014
1	Rhabdomyolysis 11/2013
1	Necrosis 11/2013
1	Brain Diseases (Brain Disorder) 03/2012
1	Kidney Diseases (Kidney Disease) 03/2011
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Temporal Lobe Epilepsy 09/2009
1	Intellectual Disability (Idiocy) 02/2009
1	Fragile X Syndrome (Martin Bell Syndrome) 02/2009
1	Wilms Tumor (Wilm's Tumor) 08/2008
1	Arthritis (Polyarthritis) 10/2005
1	Neoplasm Metastasis (Metastasis) 10/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2005
4	Oxygen (Dioxygen)IBA 10/2021 - 09/2006
4	Messenger RNA (mRNA)IBA 03/2015 - 09/2006
3	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2016 - 02/2009
3	Transcription Factors (Transcription Factor)IBA 03/2015 - 01/2011
3	IronIBA 01/2011 - 10/2005
3	CollagenIBA 09/2006 - 10/2004
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 01/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2022 - 12/2019
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 11/2013
2	EnzymesIBA 12/2019 - 10/2004
2	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2013
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2011
2	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2012
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 09/2014 - 01/2011
2	Glycine Receptors (Glycine Receptor)IBA 01/2014 - 09/2009
2	NucleolinIBA 01/2011 - 09/2006
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 09/2006 - 10/2004
2	Chelating AgentsIBA 04/2006 - 10/2005
2	2,2'-Dipyridyl (2,2 Bipyridine)IBA 04/2006 - 10/2005
2	Matrix Metalloproteinases (MMPs)IBA 10/2005 - 10/2004
1	GSK1278863IBA 10/2022
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	Tubulin ModulatorsIBA 06/2022
1	TubulinIBA 06/2022
1	Gentian Violet (Violet, Crystal)FDA Link 06/2022
1	Antineoplastic Agents (Antineoplastics)IBA 06/2022
1	PlatinumIBA 12/2019
1	animacroxamIBA 12/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2019
1	Histone Deacetylase InhibitorsIBA 12/2019
1	Angiotensin IIIBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	StaurosporineIBA 01/2019
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2018
1	Contrast MediaIBA 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	RibonucleoproteinsIBA 03/2015
1	hnRNP A2IBA 09/2014
1	ApolipoproteinsIBA 02/2014
1	Apolipoproteins E (ApoE)IBA 02/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014
1	Ligand-Gated Ion ChannelsIBA 01/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2014
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2014
1	Protons (Proton)IBA 11/2013
1	CreatinineIBA 11/2013
1	Urea (Carbamide)FDA LinkGeneric 11/2013
1	Untranslated RNA (Noncoding RNA)IBA 03/2012
1	DNA Transposable Elements (Element, IS)IBA 03/2012
1	Retroelements (Retrotransposon)IBA 03/2012
1	Endothelin-1 (Endothelin 1)IBA 03/2011
1	Carrier Proteins (Binding Protein)IBA 01/2011
1	ElementsIBA 01/2011
1	AntigensIBA 01/2011
1	Polypyrimidine Tract-Binding ProteinIBA 01/2011
1	TristetraprolinIBA 01/2011
1	phorbolIBA 01/2011
1	glycine receptor alpha3 subunitIBA 09/2009
1	Adenosine Triphosphate (ATP)IBA 09/2009
1	Fragile X Mental Retardation ProteinIBA 02/2009
1	ReninIBA 08/2008
1	Amino Acids FDA Link 08/2008
1	3' Untranslated Regions (3' UTR)IBA 09/2006
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2004
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2004
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2004

Therapy/Procedure

3	Therapeutics 12/2019 - 01/2014